CD8A and hepatocellular carcinoma: To assess the presence of CD8+CXCR5+ T cells within HCC tumors, we used flow cytometry to analyze the CD8+CXCR5+ T cell content in 20 healthy blood samples and 40 HCC specimens (Table 1), each of which included blood, peritumoral liver, and tumor tissue samples the same patient.